// App-Quantinova.ai

BSH19‐EP‐011 : Attacking Infection When the Defences Are Down: An Audit of the Management of Sepsis in Haemato‐oncology Patients in a Tertiary centre

Researchers

Presenter

  • P. D'Arienzo

Principal Investigators

  • R.J. Shaw

  • M. Johnstone

  • R. Salim

  • L. Turtle

Medical Centers

  • University of Liverpool

  • Haematology, Clatterbridge Cancer Centre

  • Institute of Infection and Global Health, University of Liverpool, Liverpool,United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Blood/haematological Diseases

  • Oncology (ONC)

Disease

  • Neutropenia

  • Lymphomas

  • Multiple Myeloma

  • Sepsis

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Piperacillin/tazobactam

  • Teicoplanin

  • CL-298741

  • Gentamicin

  • Meropenem

  • Amikacin

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A